HIV-1 variation diminishes CD4 T lymphocyte recognition

Journal of Experimental Medicine

Volumn 188, Issue 10, 1998, Pages 1785-1793

  Harcourt, Gillian C ^a,c   Garrard, Sarah ^a   Davenport, Miles P ^a   Edwards, Anne ^b   Phillips, Rodney E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Altered peptide ligands; CD4; Human immunodeficiency virus; Immune escape

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; VIRUS DNA;

ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CLINICAL ARTICLE; EPITOPE MAPPING; HELPER CELL; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CLONING, MOLECULAR; EPITOPE MAPPING; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHYTOHEMAGGLUTININS; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TETANUS TOXOID; VIRAL PROTEINS;

EID: 0032538917     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.10.1785     Document Type: Article

References (28)

1. Lane, H.C., H. Masur, G. Edgar, A.R. Whalen, A.R. Rook, and A.S. Fauci. 1983. Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
2. Clerici, M., N. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, and G.M. Shearer. 1989. Detection of three different patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1892-1899.
3. Wahren, B., L. Orfeldt-Mansson, G. Biberfield, L. Moberg, A. Sonerborg, P. Ljungman, A. Werner, R. Kurth, R. Gallo, and D. Bolognesi. 1987. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J. Virol. 61:2017-2023.
4. Rosenberg, E.S., J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 278:1447-1450.
5. Klenerman, P., U.C. Meier, R.E. Phillips, and A.J. McMichael. 1995. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immunol. 25:1927-1931.
6. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature. 369:403-407.
7. Meier, U.C., P. Klenerman, P. Griffin, W. James, B. Koppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science. 270:1360-1362.
8. Phillips, R.E., S. Rowland-Jones, D. Nixon, F. Gotch, J. Edwards, A. Ogunlesi, J. Elvin, J. Rothbard, C. Bangham, C. Rizza, and A. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:453-459.
9. Price, D.A., P.J.R. Goulder, P. Klenerman, A.K. Sewell, P.J. Easterbrook, M. Troop, C.R. Bangham, and R.E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA. 94:1890-1895.
10. Goulder, P.J.R., R.E. Phillips, R.A. Colbert, S. McAdam, G. Ogg, M.A. Novak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
11. Purbhoo, M.A., A.K. Sewell, P. Klenerman, P.J. Goulder, K.L. Hilyard, J.I. Bell, B.K. Jakobsen, and R.E. Phillips. 1998. Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA. 95:4527-4532.
12. Siliciano, R.F., T. Lawton, C. Knall, R.W. Karr, P. Berman, T. Gregory, and E.L. Reinherz. 1988. Analysis of host-virus interaction in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ depletion. Cell. 54:561-575.
13. Bunce, M., C.J. Taylor, and K.I. Welsh. 1993. Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP). Hum. Immunol. 37:201-206.
14. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C.A. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625-634.
15. Davenport, M.P., C.L. Quinn, R.M. Chicz, B.N. Green, A.C. Willis, W.S. Lane, J.I. Bell, and A.V. Hill. 1995. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc. Natl. Acad. Sci. USA. 92:6567-6571.
16. Harrer, T., E. Harrer, S.A. Kalams, P. Barbosa, A. Trocha, R.P. Johnson, T. Elbeik, M.B. Feinberg, S.P. Buchbinder, and B.D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol. 156:2616-2623.
17. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.P. Levy, J.G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variation in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129-1133.
18. Brown, J.H., T.S. Jardetzky, J.C. Gorga, L. Stern, R.S. Urban, J.L. Strominger, and D.C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:33-39.
19. Stern, L.J., J.H. Brown, T.S. Jardetzky, J.C. Gorga, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:215-221.
20. Hammer, J., B. Takacs, and F. Sinigaglia. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007-1013.
21. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from the Th cell proliferation by an altered T cell receptor ligand. Science. 252:1308-1310.
22. Madrenas, J., R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.
23. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signalling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
24. Keene, J.-A., and J. Forman. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155:768-782.
25. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C.J.M. Melief. 1998. Specific T helper cell requirements for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 187:693-702.
26. Matloubian, M., R.J. Concepcion, and R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
27. Bevan, M.M., and T.J. Braciale. 1995. Why can't cytotoxic T cells handle HIV? Proc. Natl. Acad. Sci. USA. 92:5765-5767.
28. Myers, G., J. Berzofsky, A.B. Rabson, and T.T. Smith. 1990. Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, NM.